Ken Griffin Diagnostics & Research

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
DHR
Danaher Corp
CALL
$300 Million
1.08M
Q3 2024
Added 54662.32%
TMO
Thermo Fisher Scientific Inc.
CALL
$193 Million
311K
Q3 2024
Reduced 83.09%
TMO
Thermo Fisher Scientific Inc.
PUT
$161 Million
260K
Q3 2024
Reduced 83.09%
DHR
Danaher Corp
PUT
$158 Million
567K
Q3 2024
Added 54662.32%
EXAS
Exact Sciences Corp
CALL
$33.8 Million
496K
Q3 2024
Reduced 97.67%
ILMN
Illumina, Inc.
CALL
$22.8 Million
175K
Q3 2024
Reduced 96.28%
A
Agilent Technologies, Inc.
CALL
$21.4 Million
144K
Q3 2024
Reduced 77.12%
IDXX
Idexx Laboratories Inc
CALL
$19.8 Million
39.2K
Q3 2024
Reduced 70.14%
EXAS
Exact Sciences Corp
PUT
$19 Million
279K
Q3 2024
Reduced 97.67%
IDXX
Idexx Laboratories Inc
PUT
$18.5 Million
36.6K
Q3 2024
Reduced 70.14%
A
Agilent Technologies, Inc.
PUT
$13.4 Million
90.3K
Q3 2024
Reduced 77.12%
ILMN
Illumina, Inc.
PUT
$11.9 Million
91K
Q3 2024
Reduced 96.28%
DGX
Quest Diagnostics Inc
CALL
$11.6 Million
84.6K
Q3 2024
Reduced 35.9%
CRL
Charles River Laboratories International, Inc.
CALL
$11.2 Million
56.9K
Q3 2024
Reduced 50.81%
WAT
Waters Corp
CALL
$10.3 Million
28.5K
Q3 2024
Reduced 98.8%
IQV
Iqvia Holdings Inc.
CALL
$8.74 Million
36.9K
Q3 2024
Reduced 55.44%
CRL
Charles River Laboratories International, Inc.
PUT
$7.68 Million
39K
Q3 2024
Reduced 50.81%
MEDP
Medpace Holdings, Inc.
PUT
$7.04 Million
21.1K
Q3 2024
Added 68.33%
IQV
Iqvia Holdings Inc.
PUT
$6.75 Million
28.5K
Q3 2024
Reduced 55.44%
NTRA
Natera, Inc.
PUT
$6.2 Million
48.8K
Q3 2024
Reduced 25.31%
NTRA
Natera, Inc.
CALL
$5.22 Million
41.1K
Q3 2024
Reduced 25.31%
MEDP
Medpace Holdings, Inc.
CALL
$5.2 Million
15.6K
Q3 2024
Added 68.33%
MTD
Mettler Toledo International Inc
PUT
$4.95 Million
3.3K
Q3 2024
Reduced 90.61%
DGX
Quest Diagnostics Inc
PUT
$4.77 Million
34.8K
Q3 2024
Reduced 35.9%
ICLR
Icon PLC
CALL
$3.56 Million
12.4K
Q3 2024
Reduced 57.36%
WAT
Waters Corp
PUT
$3.13 Million
8.7K
Q3 2024
Reduced 98.8%
GH
Guardant Health, Inc.
PUT
$3.07 Million
134K
Q3 2024
Reduced 89.96%
GH
Guardant Health, Inc.
CALL
$2.08 Million
90.8K
Q3 2024
Reduced 89.96%
ICLR
Icon PLC
PUT
$2.01 Million
7K
Q3 2024
Reduced 57.36%
NEO
Neogenomics Inc
CALL
$1.99 Million
135K
Q3 2024
New holding
RDNT
Rad Net, Inc.
CALL
$1.94 Million
27.9K
Q3 2024
New holding
OPK
Opko Health, Inc.
PUT
$1.73 Million
1.16M
Q3 2024
Added 626.53%
CSTL
Castle Biosciences Inc
CALL
$1.6 Million
56K
Q3 2024
Reduced 8.71%
RDNT
Rad Net, Inc.
PUT
$1.5 Million
21.6K
Q3 2024
New holding
NEOG
Neogen Corp
CALL
$1.09 Million
65.1K
Q3 2024
Reduced 59.9%
TWST
Twist Bioscience Corp
CALL
$1.03 Million
22.9K
Q3 2024
Added 3.83%
PKI
Perkinelmer Inc
CALL
$1.03 Million
8.5K
Q2 2024
Reduced 26.32%
OPK
Opko Health, Inc.
CALL
$1 Million
673K
Q3 2024
Added 626.53%
MYGN
Myriad Genetics Inc
CALL
$884,000
32.3K
Q3 2024
Reduced 96.14%
CDNA
Care Dx, Inc.
CALL
$796,000
25.5K
Q3 2024
Added 241.65%
FLGT
Fulgent Genetics, Inc.
CALL
$623,000
28.7K
Q3 2024
Added 62.65%
PKI
Perkinelmer Inc
PUT
$605,000
5K
Q2 2024
Reduced 26.32%
MYGN
Myriad Genetics Inc
PUT
$495,000
18.1K
Q3 2024
Reduced 96.14%
PSNL
Personalis, Inc.
PUT
$343,000
63.8K
Q3 2024
Reduced 90.15%
NEO
Neogenomics Inc
PUT
$334,000
22.7K
Q3 2024
New holding
CDNA
Care Dx, Inc.
PUT
$309,000
9.9K
Q3 2024
Added 241.65%
FLGT
Fulgent Genetics, Inc.
PUT
$245,000
11.3K
Q3 2024
Added 62.65%
TWST
Twist Bioscience Corp
PUT
$216,000
4.8K
Q3 2024
Added 3.83%
NEOG
Neogen Corp
PUT
$179,000
10.7K
Q3 2024
Reduced 59.9%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email